Table 2.
Overview of FOXC1 variant evaluation from ES data in 550 families with CAKUT, and for ES data of 100 negative control families with monogenic cause of SRNS.
| Cohort | CAKUT (N) | CAKUT (%) | SRNS (N) | SRNS (%) | OR | p |
|---|---|---|---|---|---|---|
| 1. Families with ES data | 550 | 100 | ||||
| 2. Families with rare FOXC1 variants (MAF <1%) | 42 | 7.64% | 1 | 1.00% | 8.185 | 0.008 |
| 3. Families with rare FOXC1 variants determined to be pathogenica | 8 | 1.45% | 0 | 0% | Infinity | 0.616 |
CAKUT congenital anomalies of the kidney and urinary tract, ES exome sequencing, MAF minor allele frequency, OR odds ratio, SRNS steroid-resistant nephrotic syndrome.
The variants need to meet the following two criteria to be determined pathogenic. Criterion 1: High evolutionary conservation or functional severity prediction: a CADD score >20, OR be predicted to be deleterious by two of three in silico prediction tools, OR have a moderate to strong conservation at least to Xenopus tropicalis. Criterion 2: Allele frequency: the variant need to present in less than 20 heterozygous alleles in gnomAD.